OM

Opaleye Management Portfolio holdings

AUM $494M
This Quarter Return
+37.55%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$198M
AUM Growth
+$198M
Cap. Flow
+$32.3M
Cap. Flow %
16.3%
Top 10 Hldgs %
58.47%
Holding
43
New
13
Increased
10
Reduced
5
Closed
7

Top Buys

1
ARAV
Aravive, Inc. Common Stock
ARAV
$5.28M
2
FGEN icon
FibroGen
FGEN
$5.23M
3
KITE
Kite Pharma, Inc.
KITE
$4.38M
4
GNMX
Aevi Genomic Medicine, Inc.
GNMX
$4.3M
5
AVDL
Avadel Pharmaceuticals
AVDL
$3.51M

Top Sells

1
NSPR icon
InspireMD
NSPR
$4.59M
2
BIND
BIND THERAPEUTICS INC
BIND
$3.87M
3
PRTA icon
Prothena Corp
PRTA
$3.48M
4
GNMK
GenMark Diagnostics, Inc
GNMK
$2.93M
5
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
$1.92M

Sector Composition

1 Healthcare 80.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CMRX
1
DELISTED
Chimerix, Inc.
CMRX
$32.4M 16.38% 805,000 +50,000 +7% +$2.01M
AGIO icon
2
Agios Pharmaceuticals
AGIO
$2.19B
$12.7M 6.43% 113,500 – –
CEMP
3
DELISTED
Cempra, Inc.
CEMP
$11.9M 6% 504,800 – –
TVTX icon
4
Travere Therapeutics
TVTX
$1.56B
$11.3M 5.69% 920,000 -80,000 -8% -$979K
ARIA
5
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$10.5M 5.29% 1,525,000 +25,000 +2% +$172K
PCYC
6
DELISTED
PHARMACYCLICS INC
PCYC
$10.4M 5.25% 85,000 – –
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
$7.84M 3.96% 140,000 – –
TTPH
8
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$7.53M 3.81% 189,700 +20,000 +12% +$794K
GERN icon
9
Geron
GERN
$893M
$5.93M 3% 1,825,000 +1,005,000 +123% +$3.27M
ARAV
10
DELISTED
Aravive, Inc. Common Stock
ARAV
$5.28M 2.67% +235,000 New +$5.28M
FGEN icon
11
FibroGen
FGEN
$47.8M
$5.23M 2.64% +191,338 New +$5.23M
INSY
12
DELISTED
Insys Therapeutics, Inc.
INSY
$5.17M 2.61% 122,500 – –
RARE icon
13
Ultragenyx Pharmaceutical
RARE
$2.89B
$4.66M 2.35% 106,200 +21,200 +25% +$930K
GNMK
14
DELISTED
GenMark Diagnostics, Inc
GNMK
$4.56M 2.3% 335,000 -215,000 -39% -$2.93M
ISEE
15
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4.49M 2.27% 100,000 +65,000 +186% +$2.92M
KITE
16
DELISTED
Kite Pharma, Inc.
KITE
$4.38M 2.21% +76,000 New +$4.38M
CDXS icon
17
Codexis
CDXS
$246M
$4.34M 2.2% 1,724,000 +34,000 +2% +$85.7K
GNMX
18
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$4.3M 2.17% +850,000 New +$4.3M
HROW icon
19
Harrow
HROW
$1.44B
$4.2M 2.12% 560,000 +57,500 +11% +$431K
CSII
20
DELISTED
Cardiovascular Systems, Inc.
CSII
$3.76M 1.9% 125,000 – –
AVDL
21
Avadel Pharmaceuticals
AVDL
$1.43B
$3.51M 1.77% +205,000 New +$3.51M
LAB icon
22
Standard BioTools
LAB
$481M
$3.2M 1.62% 95,000 +28,000 +42% +$944K
PRTK
23
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3.08M 1.56% +80,000 New +$3.08M
TRIL
24
DELISTED
Trillium Therapeutics Inc.
TRIL
$3M 1.52% +333,333 New +$3M
SUPN icon
25
Supernus Pharmaceuticals
SUPN
$2.53B
$2.91M 1.47% +350,000 New +$2.91M
1
2